Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

C4 selects CFT-8919 for progression into IND-enabling studies

May 28, 2021

Novel series of 5,5-fused bicyclic PRMT5 inhibitors as potential anticancer therapeutics

May 28, 2021

First-in-human study of ZB-716 for ER-positive, HER2-negative advanced breast cancer

May 27, 2021

Janssen initiates first-in-human trial of JNJ-75276617 in acute leukemia

May 27, 2021

SPX-1009 leads to suppression of melanoma cells

May 27, 2021

Bioardis patents CD73 inhibitors

May 27, 2021

Hangzhou Bangshun Pharmaceutical decribes new RET inhibitors

May 27, 2021

Tango Therapeutics presents new PRMT5 inhibitors

May 27, 2021

New G12C mutant KRAS inhibitors discovered at Beijing Jacobio Pharmaceuticals

May 27, 2021

Moleculin receives clearance to initiate phase Ib/II study of annamycin for STS lung metastases

May 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...